Palestine Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palestine Health Report.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 2, 2025

December 2, 2025

CORRECTION: Pluristyx Launches Organoid COMMONS, Uniting Industry Leaders to Revolutionize Drug Discovery

GlobeNewswire

December 2, 2025

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

GlobeNewswire

December 2, 2025

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025

GlobeNewswire

December 2, 2025

SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025

GlobeNewswire

December 2, 2025

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

GlobeNewswire

December 2, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

GlobeNewswire

December 2, 2025

Flame Broiler Expands Offerings With Limited-Time, Health-Conscious Charbroiled Wings

GlobeNewswire

December 2, 2025

First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin

GlobeNewswire

December 2, 2025

DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio

GlobeNewswire

December 2, 2025

Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer

GlobeNewswire

December 2, 2025

Amneal to Participate in Upcoming Investor Conferences

GlobeNewswire

December 2, 2025

Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies

GlobeNewswire

December 2, 2025

Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire

December 2, 2025

AnewHealth Names Ken Burdick Chairman of Board of Directors

GlobeNewswire

December 2, 2025

Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

GlobeNewswire

December 2, 2025

Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership

GlobeNewswire

December 2, 2025

Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

GlobeNewswire

December 2, 2025

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ Technology for Oligomer-Selective Antibodies and Recruitment Strategies for Phase 2 ALTITUDE-AD Clinical Trial at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

GlobeNewswire

December 2, 2025

TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen

GlobeNewswire

December 2, 2025

Alkeus Pharmaceuticals Appoints Renowned Retina Specialist and Biotech Executive Carlos Quezada-Ruiz, M.D., F.A.S.R.S., as Chief Medical Officer

GlobeNewswire